NDC 16729-366-16 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-366
- Requested NDC
- 16729-366-16
- Package NDCs from labels
- 16729-366-10, 16729-366-15, 16729-366-16, 16729-366-17, 16729-366-45, 16729-366-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-366-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-366-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-366-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-366-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-366-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-366-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-366-10 | EA - Each | 16729-366 | 39fc2de8-f862-4a2d-a12c-bfab23d6c60e | 1 | 2020-09-14 |
| 16729-366-15 | EA - Each | 16729-366 | 3400d9ab-caf6-4425-9c27-24a6d36b5abb | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | c2396dd4-faf2-447c-bda5-2362dbbbe352 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | 22036b58-c1fe-45b5-ae08-93fdaf716528 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 90bb2207-2eaf-495b-a222-c69d4db9e7a3 | 2026-01-14 | Warnings, Adverse reactions | 0J48LPH2TH |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | AvKARE | 1b30c3fe-5c84-0d42-e063-6394a90a81d8 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Bluevado Sunfix | ZINC OXIDE, TITANIUM DIOXIDE | Magic Blue, LLC | 2e5315bf-39f4-401c-8207-18ef6a97e024 | 2026-01-13 | Warnings | 15FIX9V2JP |
| Intellishade TruPhysical SPF 45 | TITANIUM DIOXIDE, ZINC OXIDE | Revision, LLC | e20f5dc9-e863-b090-e053-2a95a90a5044 | 2026-01-13 | Warnings | 15FIX9V2JP |
| Intellishade TruPhysical Clear SPF 50 | TITANIUM DIOXIDE, ZINC OXIDE | Revision, LLC | 1305fa94-47d5-7a42-e063-6394a90a0aba | 2026-01-13 | Warnings | 15FIX9V2JP |
| Intellishade Matte SPF 45 | OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE | Revision, LLC | e213ae87-4db2-3070-e053-2995a90a083b | 2026-01-13 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals, Inc. | 6c4cd90b-44c0-4da5-8f26-f0fa465acce4 | 2026-01-13 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 09c55798-5313-4250-8d8f-9c5644e8c1b0 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Blue Lizard Sensitive SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 9d20b230-2cce-4d90-e053-2995a90a4c03 | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Sheer SPF 50 Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Crown Laboratories | c20fce25-8120-fe5d-e053-2a95a90a53a0 | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Sheer Face SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | baed8202-21fd-3a43-e053-2a95a90ada32 | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Sensitive Face Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Crown Laboratories | 88dbd396-8955-271e-e053-2995a90a0a7a | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Baby SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 9d237fb7-4f5f-521d-e053-2a95a90a9734 | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Sensitive Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 1e4d49f4-9e77-48b5-bce5-ff04ed885a0f | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Baby SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 32d6e04a-fa30-ba48-e063-6394a90a1bbf | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Kids SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 2f780daa-4c91-5a68-e063-6394a90afd41 | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Sport SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 2f3844d8-0367-aad9-e063-6294a90a1fce | 2026-01-12 | Warnings | 15FIX9V2JP |
| Blue Lizard Sheer Face SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 30cd79da-2f25-a42a-e063-6394a90a8332 | 2026-01-12 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.